Back to results
US 2025/0326779 A1Published application
Anti-hiv compounds
AssigneeGilead Sciences, Inc.
InventorsMichael O. Clarke, Nathan D. Shapiro, Doris T. Tang
Life of this patent
Estimating the term…
Abstract
The invention provides compounds having Formula (I): or a pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions comprising the same, processes for their preparation, and methods of treating and preventing HIV infection by their administration.
Claims24
A compound of Formula (I):
- or a pharmaceutically acceptable salt thereof, wherein:
- R1 and R2 are each independently C1-4alkyl, C3-6 cycloalkyl, or O—R1A, wherein R1A is C1-4alkyl, C3-6 cycloalkyl, or a 4 to 10-membered heterocyclyl having 1 to 5 heteroatoms selected from N, O, and S;
- X1 is a 5 to 10-membered heteroaryl having 1 to 3 heteroatoms selected from N, O, and S;
- X2 is a 4 to 10-membered heterocyclyl having 1 to 5 heteroatoms selected from N, O, and S, wherein the 4 to 10-membered heterocyclyl is optionally substituted with one R3;
- R3 is a 4 to 10-membered heterocyclyl having 1 to 5 heteroatoms selected from N, O, and S;
- Z is —[C(R4)2—O]n—;
- each R4 is independently hydrogen, C1-3 alkyl, or 6 to 10-membered aryl;
- and
- n is 1 to 3.
6 more elements
(canceled)
(canceled)
-29. (canceled)
-78. (canceled)
Dependencies are inferred from the claim text.